Another great presentation on different applications of #COMS from Chantal Rosset and her colleagues from the Cité générations et maison de santé.
Thank you for showing how #COMS can improve patient care in very challenging indications.
We are often providing some free therapies for patients in need to complete their treatment. The results are in many cases stunning and end up in overwelming gratefulness from these patients. Nothing is more rewarding.
Visit our Piomic booth on the first floor at the 3rd joint SAFW meeting at the congress centre in Biel. Join us for a quick demonstration of our #COMS therapy system and its advantages in chronic wound care.
#medtech#healthcare#medicaldevices#chronicwounds#diabetescare
We are excited to announce the closing of an oversubscribed CHFM 7.5 Series A round to bring COMS® therapy into US patients’ homes. The round is led by Swiss Diabetes Venture Fund, Europe’s first venture fund dedicated to diabetes technology, joined by @VerveVentures,ZKB...
Piomic was recently selected as a 𝗚𝗿𝗼𝘂𝗻𝗱-𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗦𝘄𝗶𝘀𝘀 𝗦𝘁𝗮𝗿𝘁𝘂𝗽 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 to receive a prestigious SERI-funded EIC Accelerator Grant for our innovative solution to treat chronic wounds.#medtech#chronicwounds#COMS#woundcare#eicaccelerator
Transitional measures #HorizonEU: SERI is supporting 24 start-ups whose projects have been selected in the European Innovation Council @EUeic Accelerator 2021 calls for proposals: https://t.co/3HQNFVaomk
#SwissEU4Science#SwissEU4Innovation
Transitional measures #HorizonEU: SERI is supporting 24 start-ups whose projects have been selected in the European Innovation Council @EUeic Accelerator 2021 calls for proposals: https://t.co/3HQNFVaomk
#SwissEU4Science#SwissEU4Innovation
Dr. Kim Sarmiento, Head of Wound Care at #burjeel_darak and Maria Emilia Signer Signer, Member of the Clinic Management at @venen_klinik , were discussing their experiences in the application of #COMS in very severe cases with international experts.
https://t.co/DYSjP60AN7
After an exciting talk by J. Traber and M. Signer @venen_klinik about the advantages of COMS Therapy at the SAfW Symposium last week, we are looking forward to the excellent results from our clinical trial being published soon. #amputation#diabetescare#chronicwounds
Tomorrow on Friday, 5th of November at 09:20, Martin Berli from the @Balgrist University Hospital will present some very severe cases. Join to learn more about the potential of COMS treatment in severe wounds.
Interested in the latest treatment options for chronic wounds?
Visit us at our booth at the upcoming “9. @derbalgrist Symposium zum diabetischen Fuss” on the 4th-5th of November or at the “20th SAfW Symposium” at @technopark_zh on the 11th of November in Zurich.
#medtech
We are proud to announce that we have signed a cooperation agreement with the Geblog AG. This agreement allows streamlined access to Piomic products for a large number of wound care centers in Switzerland. https://t.co/KAc979RX7C
#medtech#healthcare#medicaldevices
Welcome to our journey!
We are very pleased to announce that Adrian Thalmann has joined our team to support our market entry in Europe. By bringing the COMS therapy to Switzerland we want to set a better future for patients in need.
https://t.co/ndZEcFJ4Kd
#medtech#healthcare
Piomic was selected out of over 180 companies to participate in the European Healthtech Investment Forum organized by Tech Tour and Business Finland.
https://t.co/cjcprDFUSQ
#medtech#venturecapital#healthcare
Piomic Medical AG awarded with the prestigious @Innosuisse Label!
This achievement honors the dedication of the entire team, which enabled us to help so many patients suffering from chronic wounds. We appreciate the support of @Innosuisse and our coaches.
#medicaldevices
Wound care has become one of the most performed services in the home care sector.
With the COMS One® Therapy, we are supporting this shift towards more applications at home and are pleased that patients are now able to receive COMS treatment in their home environment. #medtech